Celsius Global Expansion Strategic Roadmap
US
t Facts
941
US
EA
STR
O
995733
CELSIUS
LIVE
CELSIUS
LIVE PIY
SAFE
HARBOR
STATEMENT
CELSIUS
AT
C
NATED PRE-WORKOUT
AFFEINE
CELSIUS
OGENIC
PRE-WORKOUT
LIVE FIT
CLINICALLY PROVEN
THERMOGENIC
ACCELE
BURNS FAT
ETARY SUPPLEMENT
PROVIDES
Og
SUBAR
1664
1THYENES
LERATES
SUGAR
C
CELSIUS
LIVE FIT
SPARKLING GRAPE HUSH
HEALTHY ENERGY
ACCELERATES METABOLISM
BURNS BODY FAT
ETABOLISM
VATIVES
This presentation may contain statements that are not historical facts and are considered forward-
looking within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-
looking statements contain projections of Celsius Holdings' future results of operations and/or
financial position, or state other forward-looking information. In some cases you can identify these
statements by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect,"
"intend," "may," "should," "will," "would," or similar words. You should not rely on forward-looking
statements since Celsius Holdings' actual results may differ materially from those indicated by
forward-looking statements as a result of a number of important factors. These factors include, but
are not limited to: general economic and business conditions; our business strategy for expanding
our presence in our industry; anticipated trends in our financial condition and results of operation;
the impact of competition and technology change; existing and future regulations affecting our
business; and other risks and uncertainties discussed in the reports Celsius Holdings has filed
previously with the Securities and Exchange Commission. Celsius Holdings does not intend to and
undertakes no duty to update the information contained in this presentation.
This document includes certain non-GAAP financial measures. Management considers GAAP financial
measures as well as such non-GAAP financial information in its evaluation of the Company's financial
statements and believes these non-GAAP measures provide useful supplemental information to
assess the Company's operating performance and financial position. These measures should be
viewed in addition to, and not in lieu of, the Company's diluted earnings per share, operating
performance and financial measures as calculated in accordance with GAAP.View entire presentation